Glenmark Pharmaceuticals share price
Sector: Biotechnology & Drugs
You have to be logged in to add this to Watchlist.Glenmark Pharmaceuticals is trading -1.50% lower at Rs 1,043.70 as compared to its last closing price. Glenmark Pharmaceuticals has been trading in the price range of 1,063.25 & 1,033.55. Glenmark Pharmaceuticals has given 24.13% in this year & 2.01% in the last 5 days.
There are 10 analysts who have initiated coverage on Glenmark Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.
The company posted a net profit of -351.37 Crores in its last quarter.
Listed peers of Glenmark Pharmaceuticals include Glaxosmithkline Pharmaceuticals (0.02%), Biocon (1.94%), Glenmark Pharmaceuticals (-1.50%) etc.
Glenmark Pharmaceuticals has a 46.64% promoter holding & 53.36% public holding.The Mutual Fund holding in Glenmark Pharmaceuticals was at 2.25% in 31 Mar 2024. The MF holding has increased from the last quarter. The FII holding in Glenmark Pharmaceuticals was at 21.38% in 31 Mar 2024. The FII holding has decreased from the last quarter.
Glenmark Pharmaceuticals share price range
|
| ||||
|
| ||||
Glenmark Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 29,911.94 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Glenmark Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 14-Feb-24 | Quarterly Results |
| 10-Nov-23 | Quarterly Results |
| 11-Aug-23 | Quarterly Results |
| 19-May-23 | Audited Results & Final Dividend |
| 10-Feb-23 | Quarterly Results |
| 11-Nov-22 | Quarterly Results |
| 10-Aug-22 | Quarterly Results |
| 27-May-22 | Audited Results & Final Dividend |
| 11-Feb-22 | Quarterly Results |
| 12-Nov-21 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 09-Nov-23 | 06-Oct-23 | POM |
| 29-Sep-23 | 25-Aug-23 | AGM |
| 06-Aug-23 | 05-Jul-23 | POM |
| 16-Apr-23 | 15-Mar-23 | POM |
| 16-May-22 | 13-Apr-22 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 19-May-23 | - | 18-Sep-23 | 2.5 |
| 30-May-22 | - | 12-Sep-22 | 2.5 |
| 28-May-21 | - | 08-Sep-21 | 2.5 |
FAQs about Glenmark Pharmaceuticals share price
Glenmark Pharmaceuticals is trading at 1043.70 as on Thu Apr 18 2024 09:59:10. This is -1.50% lower as compared to its previous closing price of 1059.60.
The market capitalization of Glenmark Pharmaceuticals is 29451.98 Cr as on Thu Apr 18 2024 09:59:10.
The average broker rating on Glenmark Pharmaceuticals is Hold. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 4 analysts have given a hold rating
- 2 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Glenmark Pharmaceuticals is 1068.00 whereas the 52 wk low is 481.05
Glenmark Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: -
- Sector P/E: 30.14
- Dividend Yield: 0.24%
- D/E ratio: -
Glenmark Pharmaceuticals reported a net profit of 297.25 Cr in 2023.
Glenmark Pharmaceuticals Quick Links
Glenmark Pharmaceuticals Dividend | Glenmark Pharmaceuticals Bonus | Glenmark Pharmaceuticals News | Glenmark Pharmaceuticals AGM | Glenmark Pharmaceuticals Rights | Glenmark Pharmaceuticals Splits | Glenmark Pharmaceuticals Board Meetings | Glenmark Pharmaceuticals Key Metrics | Glenmark Pharmaceuticals Shareholdings | Glenmark Pharmaceuticals Profit Loss | Glenmark Pharmaceuticals Balance Sheet | Glenmark Pharmaceuticals Cashflow | Glenmark Pharmaceuticals Q1 Results | Glenmark Pharmaceuticals Q2 Results | Glenmark Pharmaceuticals Q3 Results | Glenmark Pharmaceuticals Q4 Results
Equity Quick Links
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks